1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Axial Spondyloarthritis Global Clinical Trials Review, H1, 2015

Axial Spondyloarthritis Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Axial Spondyloarthritis Global Clinical Trials Review, H1, 2015" provides data on the Axial Spondyloarthritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Axial Spondyloarthritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Axial Spondyloarthritis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Axial Spondyloarthritis Global Clinical Trials Review, H1, 2015
Table of Contents
Introduction 6
Axial Spondyloarthritis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Axial Spondyloarthritis to Immunology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Axial Spondyloarthritis to Immunology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Axial Spondyloarthritis 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Axial Spondyloarthritis Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Axial Spondyloarthritis 30
Nov 14, 2014: UCB Shows Strong Scientific Presence On Certolizumab pegol (CIMZIA) At Leading Rheumatology Meeting 30
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
AbbVie Inc. 34
Clinical Trial Overview of AbbVie Inc. 34
UCB Biosciences Inc. 35
Clinical Trial Overview of UCB Biosciences Inc. 35
Merck and Co., Inc. 36
Clinical Trial Overview of Merck and Co., Inc. 36
UCB Biosciences GmbH 37
Clinical Trial Overview of UCB Biosciences GmbH 37
Clinical Trial Overview of Top Institutes / Government 38
Glostrup University Hospital 38
Clinical Trial Overview of Glostrup University Hospital 38
Ghent University Hospital 39
Clinical Trial Overview of Ghent University Hospital 39
Charite - Universitatsmedizin Berlin 40
Clinical Trial Overview of Charite - Universitatsmedizin Berlin 40
Sociedad Espanola de Farmacologia Clinica 41
Clinical Trial Overview of Sociedad Espanola de Farmacologia Clinica 41
The First Affiliated Hospital of Zhengzhou University 42
Clinical Trial Overview of The First Affiliated Hospital of Zhengzhou University 42
Diakonhjemmet Hospital 43
Clinical Trial Overview of Diakonhjemmet Hospital 43
Rheumatism Foundation Hospital 44
Clinical Trial Overview of Rheumatism Foundation Hospital 44
Tuen Mun Hospital 45
Clinical Trial Overview of Tuen Mun Hospital 45
University hospital of North Norway 46
Clinical Trial Overview of University hospital of North Norway 46
University of Zurich 47
Clinical Trial Overview of University of Zurich 47
Five Key Clinical Profiles 48
Appendix 149
Abbreviations 149
Definitions 149
Research Methodology 150
Secondary Research 150
About GlobalData 151
Contact Us 151
Disclaimer 151
Source 151

List of Tables

Axial Spondyloarthritis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Axial Spondyloarthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Axial Spondyloarthritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Axial Spondyloarthritis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Axial Spondyloarthritis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 13
Proportion of Axial Spondyloarthritis to Immunology Clinical Trials, G7 Countries (%), 2015* 14
Axial Spondyloarthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Axial Spondyloarthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Axial Spondyloarthritis to Immunology Clinical Trials, E7 Countries (%), 2015* 17
Axial Spondyloarthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Axial Spondyloarthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Axial Spondyloarthritis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Axial Spondyloarthritis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 24
Axial Spondyloarthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Axial Spondyloarthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26
Axial Spondyloarthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Axial Spondyloarthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Axial Spondyloarthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
Axial Spondyloarthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 33
Axial Spondyloarthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 34
Axial Spondyloarthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB Biosciences Inc., 2015* 35
Axial Spondyloarthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 36
Axial Spondyloarthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB Biosciences GmbH, 2015* 37
Axial Spondyloarthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Glostrup University Hospital, 2015* 38
Axial Spondyloarthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ghent University Hospital, 2015* 39
Axial Spondyloarthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2015* 40
Axial Spondyloarthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sociedad Espanola de Farmacologia Clinica, 2015* 41
Axial Spondyloarthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by The First Affiliated Hospital of Zhengzhou University, 2015* 42
Axial Spondyloarthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Diakonhjemmet Hospital, 2015* 43
Axial Spondyloarthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rheumatism Foundation Hospital, 2015* 44
Axial Spondyloarthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tuen Mun Hospital, 2015* 45
Axial Spondyloarthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University hospital of North Norway, 2015* 46
Axial Spondyloarthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2015* 47

List of Figures

Axial Spondyloarthritis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Axial Spondyloarthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Axial Spondyloarthritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Axial Spondyloarthritis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Axial Spondyloarthritis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 13
Proportion of Axial Spondyloarthritis to Immunology Clinical Trials, G7 Countries (%), 2015* 14
Axial Spondyloarthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Axial Spondyloarthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Axial Spondyloarthritis to Immunology Clinical Trials, E7 Countries (%), 2015* 17
Axial Spondyloarthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Axial Spondyloarthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Axial Spondyloarthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Axial Spondyloarthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26
Axial Spondyloarthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Axial Spondyloarthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Axial Spondyloarthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
GlobalData Methodology 150

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.